Literature DB >> 30900617

Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system.

K Senthilkumar1, K J Maria Das2.   

Abstract

PURPOSE: Nowadays, most of the radiotherapy (RT) treatment planning systems (TPSs) uses dose or dose-volume (DV)-based cost functions for Intensity modulated radiation therapy (IMRT) fluence optimization. Recently, some of the TPSs incorporated biological-based cost function for IMRT optimization. Most of the previous studies compared IMRT plans optimized using biological-based and DV-based cost functions in two different TPSs. Hence, the purpose of the study is to compare equivalent uniform dose (EUD)-based and DV-based IMRT plans generated using the same TPS.
MATERIALS AND METHODS: Twenty patients with prostate cancer were retrospectively selected for this study. For each patient, two IMRT plans were generated using EUD-based cost function (EUD_TP) and DV-based cost (DV_Treatment Plan (TP)), respectively. The generated IMRT plans were evaluated using both physical and biological dose evaluation indices.
RESULTS: Biological-based plans ended up with a highly inhomogeneous target dose when compared to DV-based plans. For serial organs, Dnear-max or D2%(Gy) of EUD-based plans showed significant difference with DV-based plans (P = 0.003). For both rectum and bladder, there was a significant difference in mean dose and D30%(Gy) dose between EUD-based plans and DV-based plans.
CONCLUSION: In this study, we decoupled the influence of optimization parameters from the potential use of EUD-based cost functions on plan quality by generating both plans in the same TPS.

Entities:  

Keywords:  Biological-based optimization; dose volume-based optimization; equivalent uniform dose; intensity-modulated radiotherapy

Mesh:

Year:  2019        PMID: 30900617     DOI: 10.4103/jcrt.JCRT_956_16

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Dosimetric differences between intensity-modulated radiotherapy based on equivalent uniform dose and dose-volume optimization in stage III non-small cell lung cancer.

Authors:  Zhenhu Li; Qiuxia Zhao; Haitao Yin; Hongrong Ren; Yun Zhou; Chong Zhou
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Cone-Beam-CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Enables Quality Assurance and Superior Sparing of Healthy Lung.

Authors:  Philipp Hoegen; Clemens Lang; Sati Akbaba; Peter Häring; Mona Splinter; Annette Miltner; Marion Bachmann; Christiane Stahl-Arnsberger; Thomas Brechter; Rami A El Shafie; Fabian Weykamp; Laila König; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.